| | | 20,000+ Fresh Resumes Monthly | |
|
|
| |
Click here or scroll down to respond to this candidateCandidate's Name , MDStreet Address
Tel: PHONE NUMBER AVAILABLE E-mail: EMAIL AVAILABLECareer ObjectiveExperienced clinical professional with a track record of conducting clinical trials, participating in the design of study protocols, designing data collection forms, collecting, retaining, and analyzing data, currently seeking a position in a where I can contribute my extensive knowledge and experience as a valuable team member.SUMMARY OF QUALIFICATIONS:Experience in collecting/extracting data set, recruiting and consenting study participants, and working with Electronic Health Recording system (Roswell Park cancer Institute) and Mashhad University of Medical Sciences.25+ years clinical trials experience in the oncology field at Mashhad University of Medical Sciences (MUMS).Advanced medical/scientific knowledge and medical terminologiesExtensive experience in clinical research from designing clinical trial protocols, data collection, analysis, and publishing.Sound knowledge of Good Clinical Practices (ICH-GCPs) and FDA regulations.Conversant with the design and review of Case Report Form (CRF).Excellent interpersonal, analytical, conflict resolution, and problem-solving skills.Team-oriented professional with the ability to prioritize and manage time efficiently.Strong leadership skills.Computer Skills: MS OFFICE: (Word, Excel, PowerPoint), SPSSPROFESSIONAL WORK EXPERIENCE:Roswell Park Comprehensive Cancer center, Buffalo, USAData Coordinator/Research associate, Urology department October 2021-December 2023Extracting, collecting, organizing, and storing data sets.Abstracting data from the Roswell Park EHR.Recruiting and consenting study participants.Contributing to designing the study protocols.Contributing to writing manuscripts for publishing (3 publications).Mashhad University of Medical Sciences (MUMS), Mashhad, Iran 1994- July 2020Academic Staff member, Radiation OncologyDevelopment and conducting clinical research mostly in oncology covering a wide range of cancers with +40 publications.Actively involved in all aspects of clinical trials, such as developing study protocols, designing consent forms, Case Report forms, participant recruitment, data collection, and analysis.Extensive experience in data collection, sorting and performing data interpretation and analysis using Excel and/or SPSS.As a member of the Cancer Research Center (MUMS), was actively involved in arranging study teams with other disciplines to conduct multidisciplinary trials.Regular involvement in numerous conferences, workshops and CMEs as a lecturer, panelist, scientific committee member, manager, and chairman.EDUCATION:Mashhad University of Medical Sciences (MUMS)Doctor of Medicine, 1991(the degree was verified by Educational Credential Evaluators, Inc. the United States)TRAINING:Mashhad University of Medical Sciences, Mashhad, IranRadio-Oncology Specialty, 1994Certifications:Association of Clinical Research Professionals (ACRP)-Certified Professional (October-2023)Collaborative Institutional Training Initiative (CITI program) courses under requirement by Roswell Park Cancer Institute (November, December 2021)oBiomedical Research - Basic/Refresher, 46165211oGood Clinical Practice Course (US FDA focus), 46165210oBiomedical Responsible Conduct of Research, 46165212National Institutes of Health, Office of Clinical Research Education and Collaboration OutreachoIntroduction to the principal and practice of clinical Research 2020-2021Clinical Research Associate Certificate, 2020, The CRA Training Institute Houston Texas USAoICH GCP TrainingoClinical Site Monitoring (site selection, initiation, monitoring and close out)oAdverse Event ReportingoPharmacology for Clinical Research ProfessionalsCoursera e-learning (November-December 2020)oData Management for Clinical ResearchoData Visualization and Dashboards with Excel and CognooExcel Basics for Data AnalysisoBiostatics in Public Health SpecializationPublications:Shafiei SB, Shadpour S, Intes X, Rahul R, Toussi MS, Shafqat A. Performance and learning rate prediction models development in FLS and RAS surgical tasks using electroencephalogram and eye gaze data and machine learning. Surg Endosc. 2023 Sep 20. doi: 10.1007/sPHONE NUMBER AVAILABLE-y. Epub ahead of print. PMID: 37730852.Shafiei, S. B., Shadpour, S., Mohler, J. L., Attwood, K., Liu, Q., Gutierrez, C., & Toussi, M. S. (2023). Developing Surgical Skill Level Classification Model Using Visual Metrics and a Gradient Boosting Algorithm. Annals of Surgery Open, 4(2), e292Toussi, M. S., Shadpour, S., Attwood, K., Liu, Q., Gutierrez, C., Mohler, J. L., & Shafiei, S. B. (2023). MP26-09 EYE MOVEMENT BEHAVIOR ASSOCIATES WITH EXPERTISE LEVEL IN ROBOT-ASSISTED SURGERY. The Journal of Urology, 209(Supplement 4), e355.Movahed, S., Tabrizi, F. V., Pahlavani, N., Toussi, M. S., Motlagh, A., Eslami, S., ... & Norouzy, A. (2021).assessment of nutritional status and nutritional-related complications in newly diagnosed esophageal cancer patients: a cross-sectional study. Clinical Nutrition, 40(6), 4449-4455.Movahed, S., Seilanian Toussi, M., Pahlavani, N., Motlagh, A. G., Eslami, S., Nematy, M., ... & Norouzy, A. (2020). Effects of medical nutrition therapy compared with general nutritional advice on nutritional status and nutrition-related complications in esophageal cancer patients receiving concurrent chemoradiation: a randomized controlled trial. Mediterranean Journal of Nutrition and Metabolism, 13(3), 265-276Movahed S, Norouzy A, Ghanbari-Motlagh A, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, Nematy M, Ghayour-Mobarhan M, Varshoee Tabrizi F, Bozzetti F, Seilanian Toussi M*. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2315-2323.Salehi, M., Salehi, M., Shahidsales, S., Goshayeshi, G., Emadzadeh, M., Toosi, M. S., ... & Shojaei, P. (2020). Epidemiology of lung cancer in northeast of Iran: A 25-year study of 939 patients. Medical Journal of the Islamic Republic of Iran, 34, 17.Fanipakdel A, Seilanian Toussi M*, Rezazadeh F, Mohamadian Roshan N, Javadinia SA. Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy. J Cell Physiol. 2019 Jul;234(7).Fanipakdel A, Davoudi Y, Javadinia SA, Seilanian Toussi M. Pathologic Fracture as Primary Presentation of Malignant Pheochromocytoma: A Case Report. Acta Medica Iranica. 2018 Vol 56 no 12,Mirsadraei, M., Toosi, M. S., Mohebbi, S., & Khalili-Hezarjaribi, H. (2018). Evaluating dose to thyroid gland in women with breast cancer during radiotherapy with different radiation energies at supraclavicular fossa region. Journal of Radiotherapy in Practice, 17(4), 373-376Anvari, K., Seilanian Toussi, M., Ayatollahi, H., Bahadorkhan, G., Ghavam Nasiri, M., & Fazl Ersi, M. (2018). Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran. Middle East Journal of Cancer, 9(3), 179-185.Anvari K, Sima HR, Seilanian Toussi M, Anvari A, Shahidsales S, Memar B, Aledavoud SA, Forghani MN, Abdollahi MA, Ghaffarzadegan K. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran. Arch Iran Med. 2017 Apr;20(4):240-245.Farhangi H, Seilanian Toussi M, Alamdaran SA, Bagheri R. Acute Lymphoblastic Leukemia Following Nasopharyngeal Carcinoma: Report of an Unusual Case. Iran J Otorhinolaryngol. 2017 Sep; 29(94): 291294.Bagheri R, Haghi SZ, Hazrati N, Silanian Toussi M, Ahadi M. Comparison the Outcomes of Open Thoracotomy and Minimally Invasive Thoracoscopic Esophagectomy in Esophageal Cancer. J Cardiothorac Med. 2017; 5(2):569-574.Mohammadi Z, Sazgarnia A, Rajabi M, Seilanian Toussi M. Comparative study of X-ray treatment and photodynamic therapy by using 5-aminolevulinic acid conjugated gold nanoparticles in a melanoma cell line. Artificial Cells. 2016 Apr; 45(3):1-7.Jafarian AH, Taghizadeh Kermani A, Esmaeili J, Roshan NM, Seilanian-Toussi M., Omidi A, Karimi Shahri M. The role of COX-2 and Ki-67 over-expression in the prediction of pathologic response of rectal cancer to neoadjuvant chemoradiation therapy. Indian J Cancer. 2016 Oct-Dec;53(4):548-551.Anvari K, Seilanian Toussi M*, Shahidsales S, Motlagh F, Ehsaee MR, Afshari F. Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran. Iran J Cancer Prev. 2016 Aug; 9(4).Anvari K, Hosseini S, Rahighi S, Seilanian Toussi M, Roshani N, Torabi-Nami M. Intracranial meningiomas: Prognostic factors and treatment outcome in patients undergoing postoperative radiation therapy. Adv Biomed Res. 2016 May 11;5:83.Anvari K, Kalantari MR, Samini F, Shahidsales S, Seilanian-Toussi M, Ghorbanpour Z. Assessment of clinicopathologic features in patients with pituitary adenomas in Northeast of Iran: A 13-year retrospective study. Iran J Neurol. 2015 Oct 7; 14(4): 185189.Anvari K, Aledavood SA, Seilanian Toussi M*, Forghani MN, Mohtashami S, Rajabi MT, Homaee Shandiz F, Nosrati F, Nowferesti Gh. A clinical trial of neoadjuvant concurrent chemoradioptherapy followed by resection for esophageal carcinoma. J Res Med Sci 2015;20:751-6. https://www.ncbi.nlm.nih.gov/pubmed/?term=Salek%20R%5BAuthor%5D&cauthor=true&cauthor_uid=26664422Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S. A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP; Iran J Cancer Prev. 2015; 2:84-8 .Anvari K, Anvari A, Seilanian Toussi M. Esophageal Cancer and the Importance of Epidermal Growth Factor (EGFR). Reviews in Clinical Medicine. 2014 Apr, Vol 1 Issue 2.Taghizadeh-Kermani A, Yahouiyan SZ, AliAkbarian M, Seilanian Toussi M. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer: an evaluation in north-East of Iran. Iran J cancer prev. 2014 Spring;7(2):73-9.Taghizadeh-Kermani A, Jafarian AH, Ashabyamin R, Seilanian Toussi M, Pourali, L, Asadi M, Mashhadi L. The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors; Iran J Cancer Prev. 2014; 1:17-21.Anvari K, Seilanian Toussi M, Bahadorkhan Gh, Bitaghsir M, Heidari M, Fazl Ersi M. Treatment Outcomes and Prognostic Factors in Pediatric Non-brainstem Astrocytoma in North East of Iran.Iran J Cancer Prev. 2014 Spring;7(2):96-100. Soodabeh ShahidsalesAnvari K, Bahadorkhan GR, Etemad Rezaie H, Seilanian Toussi M, Prognostic Factors and Treatment Outcome in Glial Brain Tumors; Data from the Third Neuro-oncology Scientific Clubs Input Forum, 2013, Mashhad, Iran. British Journal of Medicine & Medical Research 4(18): 3538-3553, 2014.Anvari A, Seilanian Toussi M, Hosseini S. Non- Melanoma Skin Cancers: A Retrospective Study On Overall Features In Radiation Oncology Departments, Mashhad, Iran. Iranian Journal of Dermatology. Vol 17, No 1, Spring 2014Kadkhodayan S, Homaei Shandiz F, Seilanian Toussi M, Afzal Aghaee M, Farshidi F, Dehghan P. Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer, Iran J cancer prev. 2013 Fall;6(4):195-200.Seilanian Toussi M, Bagheri R, Dayani M, Anvari K, Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma, Asian Cardiovasc Thorac Ann. 2013 Aug;21(4):437-4. Shima SheibaniAnvari K, Seilanian Toussi M, Kalantari R, Naseri SH. Expression of Bcl-2 and Bax in Advanced or Metastatic Prostate Carcinoma, Urology Journal, Vol. 9 2012.Anvari K, Seilanian Toussi M, Bahadorkhan Gh, Rahigi S, +32 other authors From Fundamental Brain Tumor Science To Interdisciplinary Bedside Care; The Outcome Report From The Neuro-Oncology Scientific Club Second Meet-Up, MASHHAD, IRAN, International Journal of Medical and Clinical Research, No 5, April 2012..Towards the Real Interdisciplinary Approach in Treating Brain Tumors: Report from the Neuro-Oncology Scientific Club opening meeting - NOSC 2011-13 October- Mashhad, IR Iran, Webmed Central ONCOLOGY 2011;2(10)Seilanian Toussi M, Anvari K, Mirsadraei M. Evaluation of Intravenous Magnesium Supplementation as Prophylaxis for Cisplatin-induced Hypomagnesemia" Middle East journal of Cancer,2010;1(3):109-114.Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A, Seilanian-Toosi M. Correlation of serum and salivary CA125 levels in patients with breast cancer; The Journal Of Contemporary Dental Practice V10 N6-2009.Anvari K, Sedighi Pashaki A, Kalantari MR, Seilanian Toosi, M, Ghavam Nasiri MR, Raziee HR. BCL 2 Family Related Gens Expresion and Chemotherapy Response in diffuse Large B-Cell Lymphoma ", Iranian Journal of Pathology,2009;4(1):23-37.Saeidi Saedi H, Ghavamnasiri MR, Sailanian Toussi M*, Homaei F, Roodbari S, The assessment of prognostic factors in patients with nonmetastatic rectal Adenocarcinoma referred to Omid Hospital (Mashhad), Iran, J of Gorgan University of Medical Sciences. 2009 Vol. 11 No. 2 pp. pe28-pe32.Seilanian Toussi M, Anvari K, Aledavood SA, Nowferesti Gh. An audit of combined modality therapy for esophageal squamous cell carcinoma from a teaching hospital in Iran, Indian J gastroent. 2008 Jan-Feb;27(1):33-4.Saeidi Saedi H, Seilanian Toosi M, Mirsadraei M, Roodbari S. Evaluation of prognostic factors in patients with metastatic Breast cancer, Iranian Journal of Cancer prevention. 2008, Volume 1, Number 3; Page(s) 123 To 126.Seilanian Toosi M, Ghavam Nasiri MR, Ghafarzadegan k, Fani Pakdel A, Salek R, Anvari K. The Effect of P53 Protein Over-Expression And Its Clinical Features On The Response To Preoperative Chemoradiotherapy Of Esophageal Squamous Cell Carcinoma. Iranian Journal of Pathology. Volume 3, Isuue 1, winter 2008.Seilanian Toosi M, Tavakkol Afshar J,Ghavam Nassiri MR,Malekzadeh Moghani M, Rafatpanah, H, Brook A. The Role of Interleukin 1 Gene Polymorphism in Gastric Cancer in North-eastern Iran. Iranian Journal of Pathology. Volume 2, Issue 2, Spring 2007.Ghavam-Nasiri MR Rezaei E, Ghafarzadegan K, Seilanian-Toosi M, Malekifard. H. Expression of p53 in colorectal carcinoma: Correlation with clinicpathologic features. Archive of Iranian Medicine. Jan 2007; Volume 10, number 1: 38-42.Ghavam-Nasiri MR, Anvari K, Nowferesti GH, Silanian-Toosi M. Locally advanced Breast Cancer: An Experience In Mashhad, North-East of Iran, 1995-1999. Arch Iranian Med 2005; 8 (3): 206 210. |
